Aeglea BioTherapeutics, Inc.

Q2 2025 13F Holders

Symbol
SYRE
CUSIP
00773J202
Type
Equity
Class
COM NEW
Num filings
134
Total reported value, excl. options
$953 M
Manager Report Date Value ($000) Shares Option Type